We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
64 hedge funds and large institutions have $332M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
53% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 15
3% less funds holding
Funds holding: 66 → 64 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
25% less call options, than puts
Call options by funds: $4.87M | Put options by funds: $6.53M
49% less capital invested
Capital invested by funds: $645M → $332M (-$314M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
64
Holders Change
-2
Holders Change %
-3.03%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
9
Increased
23
Reduced
15
Closed
10
Calls
$4.87M
Puts
$6.53M
Net Calls
-$1.67M
Net Calls Change
-$1.85M
Top Buyers
Top Sellers
| 1 |
Two Sigma Investments
New York
|
-$662K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$550K |
| 3 |
D.E. Shaw & Co
New York
|
-$464K |
| 4 |
Amundi
Paris,
France
|
-$446K |
| 5 |
Millennium Management
New York
|
-$312K |
